Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Alere Medical Inc.

Division of Abbott Laboratories Inc.
www.alere.com

Latest From Alere Medical Inc.

Medtechs At The Wheel In New Health Care Landscape

2016 was a year of surprise and change in political circles, but that's nothing new for the medtech industry, which over a number of years has become accustomed to health care systems demanding different and ever-higher levels of service. Smart medtechs have been ahead of the curve, but the whole industry now factors in clients' wider needs in a holistic approach to patient care. Many companies' current M&A policies are already reflecting the changes to come.

M & A Deals

M&A Analysis: Underwhelming 2016, But Hope For 2017 US Market Boom

The last month of 2016 saw a final flurry of medtech M&A activity as companies rushed to seal deals before the New Year arrived. Medtech Insight's M&A data tracker recorded twice as many deals in December compared to the previous month, but that was not enough to boost the year's tally, which fell behind 2015.

M & A Deals

Australia’s Universal Biosensors Leaps Into Europe With Xprecia Stride

Australia device and diagnostics firm Universal Biosensors inks a deal with Siemens Healthcare to bring its Xprecia Stride coagulation analyzer into Europe, perking up its share price and outlook.

Medical Device Australia

Is Diagnostics the New Biotech...and Will Pharma Embrace It?

The early biotech industry thrived on a combination of hope and hype while diagnostics, which evolved using many of the same tools, was traditionally viewed -- and priced -- almost as a commodity. Now we're seeing the advent of complex, high-value diagnostics. As the techniques underlying tests increase in their biological complexity and the knowledge base of their developers about specific disease areas deepens, is the value proposition becoming more biotech-like?
See All

Company Information

  • Industry
  • Medical Devices
    • Monitoring Equipment & Devices
  • Services
  • Therapeutic Areas
  • Cardiovascular
  • Metabolic Disorders
  • Respiratory, Pulmonary
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Abbott Laboratories Inc.
  • Senior Management
  • Ronald D Geraty, MD, CEO
    Jon Tropsa, EVP, CFO
    Michael Majerik, EVP & Chief, Sales & Mktg.
    Gordon K Norman, MD, EVP, CSO
    Timothy Moore, MD, EVP, CMO
    Janet Tewhill, Pres. & COO
  • Contact Info
  • Alere Medical Inc.
    Phone: (775) 829-8885
    595 Double Eagle Court
    Suite 1000
    Reno, NV 89511-8991
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register